WilliamRodriguez CartagenaMD

PubMed

• Impact of Pediatric Exclusivity on Drug Labeling and Demonstrations of Efficacy.
  Wharton, G. T.,Murphy, M. D.,Avant, D.,Goldsmith, J. V.,Chai, G.,Rodriguez, W. J.,Eisenstein, E. L.> ;Pediatrics. 2014 Jul 16
• Drug labeling and exposure in neonates.
  Laughon MM, Avant D, Tripathi N, Hornik CP, Cohen-Wolkowiez M, Clark RH, Smith PB, Rodriguez W> ;JAMA Pediatr. 2014-02-01
• Migraine therapeutics in adolescents: a systematic analysis and historic perspectives of triptan trials in adolescents.
  Sun H, Bastings E, Temeck J, Smith PB, Men A, Tandon V, Murphy D, Rodriguez W> ;JAMA Pediatr. 2013-03-01
• The globalization of pediatric clinical trials.
  Dunne J, Murphy MD, Rodriguez WJ> ;Pediatrics. 2012-12-01
• Extrapolation of adult data and other data in pediatric drug-development programs.
  Dunne J, Rodriguez WJ, Murphy MD, Beasley BN, Burckart GJ, Filie JD, Lewis LL, Sachs HC, Sheridan PH, Starke P, Yao LP> ;Pediatrics. 2011-11-01
• Safety and transparency of pediatric drug trials.
  Benjamin DK, Smith PB, Sun MJM, Murphy MD, Avant D, Mathis L, Rodriguez W, Califf RM, Li JS> ;Arch Pediatr Adolesc Med. 2009-12-01
• MRI appearance of posterior cruciate ligament tears.
  Rodriguez, W.,Vinson, E. N.,Helms, C. A.,Toth, A. P.> ;AJR Am J Roentgenol. 2008 Sep 23
• Safety monitoring of drugs receiving pediatric marketing exclusivity.
  Smith PB, Benjamin DK, Murphy MD, Johann-Liang R, Iyasu S, Gould B, Califf RM, Li JS, Rodriguez W> ;Pediatrics. 2008-09-01
• Improving pediatric dosing through pediatric initiatives: what we have learned.
  Rodriguez W, Selen A, Avant D, Chaurasia C, Crescenzi T, Gieser G, Di Giacinto J, Huang S, Lee P, Mathis L, Murphy D, Murphy S, Roberts R, Sachs HC, Suarez S, Tandon V...> ;Pediatrics. 2008-03-01
• Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old.
  Belshe RB, Newman FK, Tsai TF, Karron RA, Reisinger K, Roberton D, Marshall H, Schwartz R, King J, Henderson FW, Rodriguez W, Severs JM, Wright PF, Keyserling H, Weinb...> ;J. Infect. Dis.. 2004-02-01
• Evaluation of diagnostic tests for influenza in a pediatric practice.
  Rodriguez WJ, Schwartz RH, Thorne MM> ;Pediatr. Infect. Dis. J.. 2002-03-01
• Streptococcus pneumoniae causes otitis media with higher fever and more redness of tympanic membranes than Haemophilus influenzae or Moraxella catarrhalis.
  Rodriguez WJ, Schwartz RH> ;Pediatr. Infect. Dis. J.. 1999-10-01
• Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children.
  Rodriguez WJ, Gruber WC, Groothuis JR, Simoes EA, Rosas AJ, Lepow M, Kramer A, Hemming V> ;Pediatrics. 1997-12-01
• Middle ear effusion concentrations of cefixime during acute otitis media with effusion and otitis media with effusion.
  Harrison CJ, Chartrand SA, Rodriguez W, Schwartz R, Pollack J, Thedinger B, Block SL, Hedrick JA> ;Pediatr. Infect. Dis. J.. 1997-08-01
• Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe R...
  Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EA, Meissner HC, Hemming VG, Hall CB, Lepow ML, Rosas AJ, Robertsen C, Kramer AA> ;Pediatrics. 1997-03-01
• Join now to see all